ArticleThe international journal of cardiovascular imaging2026
Optimizing TI selection in LGE imaging: pharmacokinetically standardized synthetic LGE and clinical cohort validation of a fixed 400 ms TI for LGE quantification.
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Purpose To evaluate the stability of late gadolinium enhancement (LGE) quantification across inversion times (TIs) around the null point (TInull) using pharmacokinetically generated synthetic LGE (sLGE) and to validate a fixed TI of 400 ms against conventional null-based LGE. Methods In the first cohort (n = 115), a two-compartment pharmacokinetic model was fitted to dynamic T1 maps acquired after gadolinium administration to predict T1 at 10 min, and sLGE images were simulated from the predicted T1 maps. LGE proportion (LGEp) was quantified from TInull - 60 to TInull + 100 ms, and LGEp was compared. In the second cohort (n = 80), LGEp with TI fixed at 400 ms (LGE400) was compared with conventional LGE using a Look-Locker-derived TI (LGEnull), and these images were visually compared. Results LGEp on sLGE was stable from TInull to TInull + 100 ms, with no significant differences across this range, and LGEp decreased significantly to approximately zero below TInull (p < 0.05). LGEp on sLGE with TI = 400 ms showed strong agreement with that from TInull to TInull + 30 ms (r = 0.979 to 1.0). In the second cohort, LGEp correlated strongly between LGE400 and LGEnull (r = 0.85), with minimal bias on Bland-Altman analysis. In participants without amyloidosis, the correlation further improved (r = 0.96), and both imaging approaches showed similar LGE findings. Conclusion Pharmacokinetically standardized sLGE showed stable LGE proportion above the myocardial null point and reduced LGE proportion below it. Under the evaluated 10-min post-contrast 2D inversion recovery-LGE conditions, fixed TI = 400 ms provided LGE quantification comparable to Look-Locker-determined TI in most patients.
Indexed as
Identifiers
42337213What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.